Uluslararası HastaDuyurularİletişim
HACETTEPE ÜNİVERSİTESİHASTANELERİ
Randevu Al
TR
  1. Ana Sayfa
  2. Doktorlar
  3. Doç. Dr. Saliha Esenboğa
SE

Doç. Dr.

Saliha Esenboğa

İmmünoloji · Çocuk Hastanesi

Randevu Al

Yayınlar

Kaynak: Hacettepe Üniversitesi Akademik Veri Yönetim Sistemi (AVESİS) · Tüm yayınlar (94) ↗

Makaleler 69

  1. Allogeneic Hematopoietic Stem Cell Transplantation in RhoG Deficiency: The Second Reported Patient and the First Detailed Transplant Experience.Genç Özbay Z., Isık A., Ürel Demir G., Aytekin E. S., Esenboga S., Antmen A. B., et al.Pediatric blood & cancer, 2026 (SCI-Expanded, Scopus)
  2. Clinical Heterogeneity of TNFRSF13B Variants: A Monogenic Cause or a Genetic Modifier?Cicek B., Gurel D. I., Yaz İ., Dal S. T., Bildik H. N., Erman B., et al.Immunology, 2026 (SCI-Expanded, Scopus)
  3. Hidden Burden: Liver and Gastrointestinal Involvement in Chronic Granulomatous DiseaseGenç Ozbay Z., Esenboga S., Soyak Aytekin E., Gürel D. İ., Gümüş E., Gulsen H. H., et al.IMMUNOLOGIC RESEARCH, cilt.74, sa.1, ss.1-8, 2026 (SCI-Expanded, Scopus)
  4. Could we discuss the molecular signature of immune dysregulation?Bildik H. N., Yaz İ., Esenboga S., Cagdas D. N.Clinical and experimental immunology, 2026 (SCI-Expanded, Scopus)
  5. Successful Hematopoietic Stem Cell Transplantation in a Patient With FCHO1 Deficiency.Esenboga S., Dormus T., Yaz İ., Okur F. V., Cagdas D. N., Kuşkonmaz B.Pediatric blood & cancer, cilt.73, 2026 (SCI-Expanded, Scopus)
  6. Primary Ciliary Dyskinesia: Do We Need to Test for Primary Immune Deficiency Routinely?Nayir Buyuksahin H., Emiralioglu N., Caka C., Esenboğa S., Çağdaş Ayvaz D. N., Atan R., et al.Pediatric pulmonology, cilt.61, sa.4, 2026 (SCI-Expanded, Scopus)
  7. A Survey on Environmental Protective and Risk Factors and Awareness Related to Epithelial Barrier Integrity, Microbiome and Allergic Diseases.Bakirtas A., Kiykim A., Baskin A. K., Anil H., Bozkurt H. B., Cimen S. S., et al.Allergy, cilt.81, sa.3, ss.930-933, 2026 (SCI-Expanded, Scopus)
  8. CD137 deficiency patients: two new patients and review of the literature.Genc Ozbay Z., Kocali B., Ilgun Gurel D., Yaz İ., Ulum B., Aktas D., et al.Clinical and experimental immunology, cilt.220, sa.1, 2026 (SCI-Expanded, Scopus)
  9. Malignancies in the context of Inborn errors of immunity: an Immunologist’s viewGenc Ozbay Z., Soyak Aytekin E., Esenboga S., Çağdaş Ayvaz D. N.EXPERT REVIEW OF CLINICAL IMMUNOLOGY, cilt.22, sa.1, ss.223-231, 2026 (SCI-Expanded, Scopus)
  10. Severe onset type 1 diabetes mellitus with unusual manifestations due to CD70 deficiency: novel pathway in deciphering the etiopathogenesis of type 1 diabetes mellitus, and the experience with hematopoietic stem cell transplantationUnsal Y., Sancak E., Çelik Ertaş N. B., Langley D. B., Bildik H. N., Akarsu A., et al.PEDIATRIC DIABETES, cilt.2026, sa.1, ss.1-5, 2026 (SCI-Expanded, Scopus)
  11. From Interferon Signature to the Clinical Landscape: Type I InterferonopathiesYaz İ., Ozen S., Bildik H. N., Ipsir C., Unal D., Esenboga S., et al.Arthritis and Rheumatology, 2026 (SCI-Expanded, Scopus)
  12. Transient hypogammaglobulinemia of infancy: revisiting an old entityGenç Ozbay Z., ESENBOĞA S.Expert Review of Clinical Immunology, 2026 (SCI-Expanded, Scopus)
  13. Overlap of familial Mediterranean fever and APLAID treated with anakinra: a case-based review.Akoglu G., Yaz İ., Esenboga S., Yilmaz S., Mulazimoglu D. D., Cagdas D. N.Clinical rheumatology, cilt.44, ss.5143-5154, 2025 (SCI-Expanded, Scopus)
  14. Rubella-associated granuloma in a patient with a compound heterozygous RAG1 defect and review of the literatureAkarsu A., Sonmez G., Schiefer A., Ozcan H. N., Üner M., Esenboga S., et al.IMMUNOLOGIC RESEARCH, cilt.73, sa.1, ss.1-5, 2025 (SCI-Expanded, Scopus)
  15. Lessons From COVID-19 on Inborn Errors of Immunity: A Five-Year Narrative Review.Sonmez G., Gunduz G., Esenboga S., Cagdas D. N.Scandinavian journal of immunology, cilt.102, sa.5, 2025 (SCI-Expanded, Scopus)
  16. Expansion of Myeloid-Derived Suppressor Cells and Lymphocyte Apoptosis Beyond B-Cell Deficiency in X-Linked Agammaglobulinemia.Ceylan A., Kulhas Celik I., Keles S., Celebi Celik F., Karali Y., Meric Z., et al.Scandinavian journal of immunology, cilt.102, sa.5, 2025 (SCI-Expanded, Scopus)
  17. Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX PatientsYaz İ., Oskay Halacli S., Ipsir C., Ulum B., Soyak Aytekin E., Bildik H. N., et al.JOURNAL OF CLINICAL IMMUNOLOGY, cilt.45, sa.1, 2025 (SCI-Expanded, Scopus)
  18. Monocyte plasticity and HLA-DR expression in patients with X-linked agammaglobulinemia.Artac H., Ceylan A., Kulhas Celik I., Celebi Celik F., Karali Y., Meric Z., et al.Immunologic research, cilt.73, sa.1, ss.133, 2025 (SCI-Expanded, Scopus)
  19. Pediatric and Adult Inborn Errors of Immunity and COVID‐19: A Comparative StudyÇağdaş Ayvaz D. N., Esenboga S., Akarsu A., Cevik N. N., Topeli A., Ozsurekci Y., et al.JOURNAL OF MEDICAL VIROLOGY, cilt.97, sa.9, ss.1-10, 2025 (SCI-Expanded, Scopus)
  20. Comprehensive αβ T-Cell Receptor Repertoire Analysis Reveals a Unique CD8+ TCR Landscape in DOCK8-Deficient Patients.Bozkurt C., Cildir G., Aba U., Erdogan R. K., Warnock N. I., Kok C. H., et al.Allergy, cilt.80, sa.9, ss.2519-2530, 2025 (SCI-Expanded, Scopus)
  21. Regulatory T Cell Sub-Populations in Patients with Distinct Autoimmune/Inflammatory Diseases With or Without Inborn Errors of ImmunityOskay Halacli S., Inan D., Esenboga S., Bildik H. N., Bolat A. B., Tezcan I., et al.DIAGNOSTICS, cilt.15, sa.15, ss.1-5, 2025 (SCI-Expanded, Scopus)
  22. Phenotypic diversity in NAXE mutationsSolmaz I., Yalnızoğlu D., Dursun A., Çıkı K., Akar H. T., Özgül R. K., et al.NEUROLOGICAL SCIENCES, cilt.46, sa.6, ss.2819-2828, 2025 (SCI-Expanded, Scopus)
  23. Five Patients with Two Novel Homozygous Variants in CD3 Subunits and Comprehensive Review of the Literature.Sonmez G., Kazancıoglu A., Yazarkan Y., Tenekeci A. K., Yaz İ., Esenboga S., et al.The journal of allergy and clinical immunology. In practice, cilt.13, 2025 (SCI-Expanded, Scopus)
  24. Amyloidosis in Human Inborn Errors of Immunity Predicts Poor Prognosis.Aytekin E. S., Tagiyev A., Silleli O., Samur İ., Demirel F., Esenboğa S., et al.Journal of clinical immunology, cilt.45, sa.1, ss.88, 2025 (SCI-Expanded, Scopus)
  25. A patient with RFX5 variant causing an expression defect in both HLA ABC and HLA DR.Goktas S., Sonmez G., Şahin A., Çevik N. N., Caka C., Yaz İ., et al.Immunologic research, cilt.73, sa.1, ss.72, 2025 (SCI-Expanded, Scopus)
  26. Recurrent eosinophilia with a novel homozygous ARPC1B mutation.Sonmez G., Ulum B., Tenekeci A. K., Caka C., Şahin A., Kazancıoğlu A., et al.Frontiers of medicine, cilt.19, sa.1, ss.174-180, 2025 (SCI-Expanded, Scopus)
  27. Human FCHO1 deficiency: review of the literature and additional two cases.Özdemiral C., Yaz İ., Esenboga S., Nabiyeva Cevik N., Bildik H. N., Kilic M., et al.Clinical and experimental immunology, cilt.219, sa.1, 2025 (SCI-Expanded, Scopus)
  28. Respiratory system evaluation of adult primary immunodeficiency patients: a tertiary care center experienceKaya S. B., Çakmak M. E., Bostan Ö. C., Damadoğlu E., Karakaya G., Kalyoncu A. F., et al.POSTEÓPY HIGIENY I MEDYCYNY DOSÂWIADCZALNEJ, cilt.79, sa.1, ss.1-3, 2025 (SCI-Expanded, Scopus)
  29. Characteristics of patients with low serum IgE levels and selective IgE deficiency: Data from an immunodeficiency referral centerÜnsal H., Ekinci A., Aliyeva G., Bildik H. N., Esenboğa S., Çağdaş Ayvaz D. N.CLINICAL IMMUNOLOGY, cilt.1, sa.1, ss.1-7, 2025 (SCI-Expanded, Scopus)
  30. A large cohort from an immunology reference center and an algorithm for the follow-up of chronic neutropenia.Caka C., Ergenoğlu D. N., Sinanoğlu N., Maslak I. C., Bildik H. N., Çiçek B., et al.Journal of clinical immunology, cilt.45, sa.1, ss.38, 2024 (SCI-Expanded, Scopus)
  31. Human DNA-dependent protein kinase catalytic subunit deficiency: a comprehensive review and update.Adelon J., Abolhassani H., Esenboga S., Fouyssac F., Cagdas D. N., Tezcan I., et al.The Journal of allergy and clinical immunology, cilt.154, ss.1300-1312, 2024 (SCI-Expanded, Scopus)
  32. Newborn screening for SCID: the very first prospective pilot study from TürkiyeHaskologlu S., Kocak S., Tufan L. S., Aksoy F. E., Bastug D., Oner D. A., et al.FRONTIERS IN IMMUNOLOGY, cilt.15, ss.1-12, 2024 (SCI-Expanded, Scopus)
  33. A single center experience on PI3K/AKT/MTOR signaling defects: Towards pathogenicity assessment for four novel defects.Bildik H. N., Esenboga S., Halaclı S., Karaatmaca B., Aytekin E. S., Nabiyeva N., et al.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, cilt.35, sa.9, 2024 (SCI-Expanded, Scopus)
  34. Evaluation of patients with Primary Ciliary Dyskinesia in terms of humoral immunodeficiencyBuyuksahin H. N., EMİRALİOĞLU ORDUKAYA N., CAKA C., ESENBOĞA S., ÇAĞDAŞ AYVAZ D. N., ATAN R., et al.EUROPEAN RESPIRATORY JOURNAL, 2024 (SCI-Expanded, Scopus)
  35. Genetic Evaluation of the Patients with Clinically Diagnosed Inborn Errors of Immunity by Whole Exome Sequencing: Results from a Specialized Research Center for Immunodeficiency in Türkiye.Erman B., Aba U., Ipsir C., Pehlivan D., Aytekin C., Cildir G., et al.Journal of clinical immunology, cilt.44, sa.7, ss.157, 2024 (SCI-Expanded, Scopus)
  36. False Negative Next-Generation-Sequencing Analysis in a Lipopolysa ccharide-Responsive Beige-Like Anchor Defect.Ünal T., Esenboğa S., Oskay Halaçlı S., Tezcan I., Çağdaş D. N.Turkish archives of pediatrics, cilt.59, sa.2, ss.221-223, 2024 (ESCI, TRDizin)
  37. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre.Karaatmaca B., Cagdas D. N., Esenboga S., Erman B., Tan C., Ozgur T. T., et al.Clinical and experimental immunology, cilt.215, sa.2, ss.160-176, 2024 (SCI-Expanded, Scopus)
  38. The spectrum of side effects associated with COVID-19 vaccines in patients with inborn errors of immunity.Özdemiral C., Cevik N. N., Yavuz G., Gormez O., Zengin A. B., Esenboga S., et al.Clinical immunology (Orlando, Fla.), cilt.259, ss.109878, 2024 (SCI-Expanded, Scopus)
  39. GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.Park A. Y., Leney-Greene M., Lynberg M., Gabrielski J. Q., Xu X., Schwarz B., et al.Nature immunology, cilt.25, ss.282-293, 2024 (SCI-Expanded, Scopus)
  40. Psychosocial Functionality in Adolescents with Inborn Errors of Immunity During the COVID-19 PandemicGüven A. G., Esenboğa S., Kızılkan M. P., Aslan C., Akarsu A., Karabulut E., et al.Turkish Journal of Pediatric Disease, cilt.1, sa.1, ss.1-2, 2024 (TRDizin)
  41. Comparative analysis of protein expression profiles with genotypes in the diagnosis of Inborn Errors of Immunity.Oskay Halacli S., Cagdas D. N., Esenboga S., Inan D., Yaz İ., Cicek B., et al.Scandinavian journal of clinical and laboratory investigation, cilt.84, sa.7-8, ss.547-556, 2024 (SCI-Expanded, Scopus)
  42. A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in TurkeyÜnsal H., Caka C., Bildik H. N., Esenboğa S., Kupesiz A., Kuşkonmaz B. B., et al.Scandinavian Journal of Immunology, cilt.99, sa.1, 2024 (SCI-Expanded, Scopus)
  43. COVID-19-related multiple inflammatory syndrome-C and pulmonary embolism in Aicardi-Goutries syndrome.Çevik N. N., Aytekin E., Esenboğa S., Özbek B., Aytaç Ş. S., Özen S., et al.Pediatric pulmonology, cilt.58, ss.3326-3329, 2023 (SCI-Expanded, Scopus)
  44. Eosinophilia in children: characteristics, etiology and diagnostic algorithm.Cetinkaya P. G., Aytekin E. S., Esenboga S., Cagdas D. N., Sahiner Ü. M., Sekerel B. E., et al.European journal of pediatrics, cilt.182, sa.6, ss.2833-2842, 2023 (SCI-Expanded, Scopus)
  45. Orai1 defect in a patient with disseminated cmv infection and severe hypotoniaDeveci K., Esenboğa S., Bildik H. N., Ocak M., Gülşen H. H., Ertuğrul İ., et al.TURKISH JOURNAL OF PEDIATRICS, cilt.65, sa.4, ss.698-703, 2023 (SCI-Expanded, Scopus, TRDizin)
  46. Thymic Development, Inborn Errors of Immunity with Thymic Dysfunction and Thymic TransplantationESENBOĞA S.Asthma Allergy Immunology, cilt.21, sa.2, ss.82-88, 2023 (ESCI, Scopus, TRDizin)
  47. Childhood-onset Takayasu arteritis and immunodeficiency: case-based review.Sener S., Basaran O., Batu E. D., Atalay E., Esenboga S., Cagdas D. N., et al.Clinical rheumatology, cilt.41, sa.9, ss.2883-2892, 2022 (SCI-Expanded, Scopus)
  48. Antimycobacterial prophylaxis regarding Bacillus Calmette-Guérin -associated complications in children with primary immunodeficiencyOzsezen B., Yalçın E., Ademhan Tural D., Sunman B., Nayır Buyuksahin H., Guzelkas İ., et al.Respiratory Medicine, cilt.200, 2022 (SCI-Expanded, Scopus)
  49. TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.Esenboga S., Cagdas D. N., Alkanat N. E., Güler Tezel G., Ersoy Evans S., Boztug K., et al.Journal of cosmetic dermatology, cilt.21, sa.5, ss.2263-2267, 2022 (SCI-Expanded, Scopus)
  50. Evaluation of Health Status and Quality of Life in Patients Using Intravenous and Subcutaneous Forms of Immunoglobulin ReplacementEsenboğa S., Akarsu A., Bildik H. N., Çağdaş Ayvaz D. N., Tezcan İ.Ankara Üniversitesi Tıp Fakültesi Mecmuası, cilt.75, sa.1, ss.77-83, 2022 (TRDizin)
  51. Double Trouble in an Adult Patient with UNC13D mutation: EBV-Associated Lymphoproliferation and Kaposi SarcomaNabiyeva N., Esenboga S., Ozdemir E., Berber I., Yaz İ., Bildik H. N., et al.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.32, sa.4, ss.246-250, 2022 (SCI-Expanded, Scopus)
  52. Psychological burden of asthma in adolescents and their parentsDut R., Soyer O., Sahiner Ü. M., Esenboga S., Gur Cetinkaya P., Akgul S., et al.JOURNAL OF ASTHMA, cilt.59, sa.6, ss.1116-1121, 2022 (SCI-Expanded, Scopus)
  53. Respiratory system findings in pediatric patients with primary immunodeficiencyEsenboga S., Oguz B., Cagdas D. N., Karaatmaca B., Emiralioglu N., Yalcin E., et al.Pediatric Pulmonology, cilt.56, sa.12, ss.4011-4019, 2021 (SCI-Expanded, Scopus)
  54. Clinical and laboratory findings in patients with leukocyte adhesion deficiency type I: A multicenter study in TurkeyYaz İ., Ozbek B., Bildik H. N., Tan C., Oskay Halacli S., Soyak Aytekin E., et al.CLINICAL AND EXPERIMENTAL IMMUNOLOGY, cilt.206, sa.1, ss.47-55, 2021 (SCI-Expanded, Scopus)
  55. Diversity in Serine/Threonine Protein Kinase-4 Deficiency and Review of the LiteratureCagdas D. N., Halacli S., Tan C., Esenboğa S., Karaatmaca B., Cetinkaya P. G., et al.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, cilt.9, sa.10, ss.3752-3770, 2021 (SCI-Expanded, Scopus)
  56. COVID-19 in Patients with Primary ImmunodeficiencyEsenboga S., Ocak M., Akarsu A., Bildik H. N., Cagdas D. N., Iskit A. T., et al.JOURNAL OF CLINICAL IMMUNOLOGY, cilt.41, sa.7, ss.1515-1522, 2021 (SCI-Expanded, Scopus)
  57. Clinical and Immunological Characteristics of 63 Patients with Chronic Granulomatous Disease: Hacettepe ExperienceAkar H. T., Esenboga S., Cagdas D. N., Halacli S., Ozbek B., van Leeuwen K., et al.JOURNAL OF CLINICAL IMMUNOLOGY, cilt.41, sa.5, ss.992-1003, 2021 (SCI-Expanded, Scopus)
  58. Pistachio and cashew nut allergy in childhood: Predictive factors towards development of a decision treeCetinkaya P., Karaguzel D., Esenboğa S., Sahiner Ü. M., Soyer O., Buyuktiryaki B., et al.ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, cilt.39, sa.1, ss.53-61, 2021 (SCI-Expanded, Scopus)
  59. Predictors for late tolerance development in food protein-induced allergic proctocolitisCetinkaya P., Kahveci M., Karaatmaca B., Esenboga S., Sahiner Ü. M., Sekerel B. E., et al.ALLERGY AND ASTHMA PROCEEDINGS, cilt.41, sa.1, 2020 (SCI-Expanded, Scopus)
  60. Physicians prescribe adrenaline autoinjectors, do parents use them when needed?Esenboga S., Kahveci M., Cetinkaya P., Sahiner Ü. M., Soyer Ö., Buyuktiryaki B., et al.ALLERGOLOGIA ET IMMUNOPATHOLOGIA, cilt.48, sa.1, ss.3-7, 2020 (SCI-Expanded, Scopus)

AVESİS'te 69 kaydın tamamı →

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 23

  1. Good Sendromu: Olgu SunumuKAZANCIOĞLU A., CAKA C., ALİYEVA G., ÜSTÜN C., SOYAK AYTEKİN E., ESENBOĞA S., et al.XXX. ULUSLARARASI KATILIMLI ULUSAL ALLERJİ KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 27 Kasım - 01 Aralık 2024, (Özet Bildiri)
  2. IPEX Sendromu Tek Merkez DeneyimiYAZ İ., OSKAY HALAÇLI S., İPŞİR C., ULUM B., ESENBOĞA S., BİLDİK H. N., et al.XXX. ULUSLARARASI KATILIMLI ULUSAL ALLERJİ KLİNİK İMMÜNOLOJİ KONGRESİ, Antalya, Türkiye, 27 Kasım - 01 Aralık 2024, (Özet Bildiri)
  3. Büyüme Gelişme Geriliği, Kraniofasiyal Dismorfizm ve Kombine İmmün Yetmezlik ile Seyreden Bir Olgu: KMT2C MutasyonuFATHELBAB J., DEMİRSU A., YAZ İ., KAZANCIOĞLU A., SOYAK AYTEKİN E., ESENBOĞA S., et al.XXX. ULUSLARARASI KATILIMLI ULUSAL ALLERJİ KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 27 Kasım 2024, (Özet Bildiri)
  4. Immunodeficiency accompanying severe asthma and chronic urticariaTuncay G., Bostan O. C., Cihanbeylerden M., Kayikci H., Esenboga S., Damadoglu E., et al.Annual Hybrid Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI), Hamburg, Almanya, 9 - 11 Haziran 2023, (Özet Bildiri)
  5. ERİŞKİN İMMÜNYETMEZLİKLİ HASTALARDA SAĞLIKLA İLİŞKİLİ YAŞAM KALİTESİ VE ÇALIŞMA DURUMLARININ BELİRLENMESİMADEN S., ÖZDEDE M., ÖZDEMİRAL C., ESENBOĞA S., SÖNMEZER M. Ç., İNKAYA A. Ç., et al.25. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Türkiye, 8 Aralık - 12 Kasım 2023, (Tam Metin Bildiri)
  6. AICARDI-GOUTRIES SENDROMU VE COVID-19 İLİŞKİLİ MIS-CNABİYEVA ÇEVİK N., ESENBOĞA S., SOYAK AYTEKİN E., ÖZDEMİRAL C., ÖZBEK B., KARAGÖZ T., et al.8. KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 26 - 29 Ekim 2022, (Özet Bildiri)
  7. CMV Miyokarditi ve Ağır Hipotonisi Olan Bir Hastada ORAI1 DefektiESENBOĞA S., DEVECİ K., AKARSU A., OCAK M., BİLDİK H. N., YAZ İ., et al.7. Klinik İmmünoloji Kongresi, Türkiye, 6 - 09 Ekim 2021, ss.64-65, (Özet Bildiri)
  8. MYH9 Eksikliği: Herediter Makrotrombositopeni OlgusuÖZBEK B., YAZ İ., ESENBOĞA S., BİLDİK H. N., AKARSU A., AKSU T., et al.7. klinik İmmünoloji Kongresi, Türkiye, 6 - 09 Ekim 2021, cilt.1, ss.63, (Özet Bildiri)
  9. Primer İmmün Yetmezlik Şüpheli Hastalarda DOCK8 Protein İfadesinin İncelenmesiİnan D., OSKAY HALAÇLI S., YAZ İ., ESENBOĞA S., ÇAĞDAŞ AYVAZ D. N., TEZCAN F. İ.7. klinik İmmünoloji Kongresi, Türkiye, 6 - 09 Ekim 2021, cilt.1, ss.90, (Özet Bildiri)
  10. Türkiye’de Görev Yapan Hekimlerin Primer İmmünyetmezlik Farkındalığının DeğerlendirilmesiESENBOĞA S., OCAK M., SOYAK AYTEKİN E., BİLDİK H. N., ÇAĞDAŞ AYVAZ D. N., TEZCAN F. İ.6. KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 31 Ekim - 01 Kasım 2020, (Özet Bildiri)
  11. İmmünglobulin E yüksekliği nedeni ile izlenen hastaların değerlendirilmesi; klinik laboratuvar özellikler ve moleküler çalışmalar, hangisi hiperimmünglobulin E sendromu?BİLDİK H. N., OCAK M., SOYAK AYTEKİN E., KENDİRCİ N., ESENBOĞA S., ÇAĞDAŞ AYVAZ D. N., et al.6. KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 31 Ekim - 01 Kasım 2020, (Özet Bildiri)
  12. HACETTEPE ÜNİVERSİTESİ ÇOCUK İMMÜNOLOJİ BÖLÜMÜNDE SON BEŞ YILDA İZLENEN HASTALARIN DAĞILIMLARIKOÇALİ B., SOYAK AYTEKİN E., ÇAĞDAŞ AYVAZ D. N., GÜR ÇETİNKAYA P., ESENBOĞA S., KARAATMACA B., et al.6. KLİNİK İMMÜNOLOJİ KONGRESİ, Türkiye, 31 Ekim - 01 Kasım 2020, (Tam Metin Bildiri)
  13. RLTPR/CARMIL2 Geninde Mutasyon Sonucu Ortaya Çıkan Tekrarlayan CMV Retinitli Olgu SunumuÇAĞDAŞ AYVAZ D. N., ESENBOĞA S., SOYAK AYTEKİN E., TAN Ç., TEZCAN F. İ.5. Klinik İmmünoloji Kongresi, Türkiye, 20 - 23 Mart 2019, ss.22, (Özet Bildiri)
  14. Diskoid lupus tanısı ile izlenen erişkin bir hastada, kronik granulomatöz hastalık: İmmünoloji konsültasyonunun önemiESENBOĞA S., ERMAN B., TAN Ç., Çelik Başaran N., DOĞAN GÜNAYDIN S., ÇAĞDAŞ AYVAZ D. N., et al.2. Klinik İmmünoloji Kongresi, Antalya, Türkiye, 31 Mart - 03 Nisan 2016, (Özet Bildiri)
  15. DİSKOİD LUPUS TANISI İLE İZLENEN ERİŞKİN BİR HASTADA KRONİK GRANÜLOMATÖZ HASTALIK: İMMÜNOLOJİ KONSÜLTASYONUNUN ÖNEMİESENBOĞA S., ERMAN B., TAN Ç., ÇALIK BAŞARAN N., DOĞAN S., ÇAĞDAŞ AYVAZ D. N., et al.2.KLİNİK İMMÜNOLOJİ KONGRESİ, Antalya, Türkiye, 31 Mart - 03 Nisan 2016, ss.36, (Özet Bildiri)
  16. Erişkin Hastalarda Farklı Klinikte Ortaya Çıkan Kombine İmmün Yetmezlik OlgularıÇALIK BAŞARAN N., ÇAĞDAŞ AYVAZ D. N., ESENBOĞA S., Betül K., BÖLEK E. Ç., TEZCAN F. İ.2. KLİNİK İMMÜNOLOJİ KONGRESİ, Antalya, Türkiye, 31 Mart - 03 Nisan 2016, ss.32, (Özet Bildiri)
  17. Aksiller Lenfadenit Tanısı ile Başvuran Bir Hastada IL12RB1 DefektiBEKTAŞ H., ESENBOĞA S., EMİRALİOĞLU N., TAN Ç., YALÇIN E. E., ÇAĞDAŞ AYVAZ D. N., et al.1. Klinik İmmünoloji Kongresi, Antalya, Türkiye, 9 - 12 Nisan 2015, (Özet Bildiri)
  18. Unmasking Immune Dysregulation: Is Eosinophilic Esophagitis an Early Clue to Inborn Errors of Immunity?İLGÜN GÜREL D., SOYAK AYTEKİN E., ESENBOĞA S., DEMİR H., ORHAN D., UYSAL SOYER Ö., et al.
  19. Evaluation of sleep and quality of life inpatients receiving immunoglobulin replacement therapyfor inborn errors of immunityIRMAK C., ESENBOĞA S., ÇAĞDAŞ AYVAZ D. N.
  20. Evaluation of genetic results of patients withataxia-telangiectasia: a single center experience- Flash talks (FT) and Pitch session (PiS)IRMAK C., SAĞLAM R., YAZ İ., ESENBOĞA S., TEZCAN F. İ., ÇAĞDAŞ AYVAZ D. N.
  21. Inflammatory parameters and innate lymphoid cells in chilhood interstitial lung diseases: a prospective studyHizal M., Oskay Halaçlı S., Nayır-Büyükşahin H, H., Çiftçier B., Yılmaz K., Emiralioglu Ordukaya N., et al.
  22. INVESTIGATION OF COMBINED IMMUNODEFICIENCIES, IMMUNODEFICIENCIES WITH IMMUNEDYSREGULATION AND INNATE IMMUNE SYSTEM DEFECTS WITH ADVANCED IMMUNOLOGICAL AND GENETIC METHODSESENBOĞA S., HASKOLOĞLU Z. Ş., KELEŞ S., TAN Ç., GÜNER Ş. N., ÇAĞDAŞ AYVAZ D. N., et al.
  23. Protein expression profiles in patients with primary immunodeficienciesHalacli S. O., Cagdas D. N., Akarsu A., Kahveci M., Aytekin E. S., Inan D., et al.cilt.51, ss.364, (Özet Bildiri)

Kitaplar 2

  1. Primer İmmün Yetmezlik HastalıklarındaHematopoietik Kök Hücre TransplantasyonuESENBOĞA S., ÇAĞDAŞ AYVAZ D. N., TEZCAN F. İ.Yurdakök Pediatri, Murat Yurdakök, Editör, Güneş, Ankara, ss.1-2, 2017
  2. Virus-Related Lymphoproliferation and Cancer Development in Inborn Errors of ImmunityESENBOĞA S., ÇAĞDAŞ AYVAZ D. N.

İletişim

Bölüm
İmmünoloji, Çocuk Hastanesi

Son güncelleme: